Do analysts recommend PETV or NVNO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Is PETV or NVNO more profitable?

enVVeno Medical has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. enVVeno Medical's return on equity of -62.28% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets PetVivo -902.82% -4,813.07% -281.78% enVVeno Medical N/A -62.28% -56.83%

Do analysts prefer CTSO or NVNO?

Cytosorbents presently has a consensus target price of $5.38, suggesting a potential upside of 1,244.09%. Given Cytosorbents' higher probable upside, analysts clearly believe Cytosorbents is more favorable than enVVeno Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cytosorbents 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Do analysts rate LFWD or NVNO?

Lifeward currently has a consensus target price of $10.00, indicating a potential upside of 34.23%. Given Lifeward's higher probable upside, equities research analysts plainly believe Lifeward is more favorable than enVVeno Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lifeward 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Is LFWD or NVNO more profitable?

enVVeno Medical has a net margin of 0.00% compared to Lifeward's net margin of -123.66%. enVVeno Medical's return on equity of -62.28% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Lifeward -123.66% -243.14% -97.39% enVVeno Medical N/A -62.28% -56.83%

Do analysts recommend NVNO or ZJYL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, NVNO or ZJYL?

Jin Medical International has higher revenue and earnings than enVVeno Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio enVVeno Medical N/A N/A -$19.47M -$19.33 N/A Jin Medical International $20.69M 12.81 $1.19M N/A N/A

Is NVNO or ZJYL more profitable?

Jin Medical International's return on equity of 0.00% beat enVVeno Medical's return on equity. Company Net Margins Return on Equity Return on Assets enVVeno Medical N/A -62.28% -56.83% Jin Medical International N/A N/A N/A

Do analysts recommend ADGM or NVNO?

Adagio Medical currently has a consensus price target of $3.50, indicating a potential upside of 405.63%. Given Adagio Medical's higher probable upside, research analysts clearly believe Adagio Medical is more favorable than enVVeno Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Which has stronger earnings and valuation, ADGM or NVNO?

enVVeno Medical is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Adagio Medical N/A N/A -$25.08M -$1.48 N/A enVVeno Medical N/A N/A -$19.47M -$19.33 N/A

Is ADGM or NVNO more profitable?

enVVeno Medical's return on equity of -62.28% beat Adagio Medical's return on equity. Company Net Margins Return on Equity Return on Assets Adagio Medical N/A -661.85% -73.35% enVVeno Medical N/A -62.28% -56.83%

enVVeno Medical (NVNO) Competitors

$10.85 +0.00 (+0.03%)

Closing price 08/14/2026 03:59 PM Eastern

Extended Trading

$10.27 -0.59 (-5.41%)

As of 08/14/2026 07:58 PM Eastern

Compare

NVNO vs. PETV, CTSO, LFWD, ZJYL, and ADGM

Should you buy enVVeno Medical stock or one of its competitors? enVVeno Medical's main competitors and comparable companies include PetVivo (PETV), Cytosorbents (CTSO), Lifeward (LFWD), Jin Medical International (ZJYL), and Adagio Medical (ADGM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does enVVeno Medical compare to PetVivo?

PetVivo (NASDAQ:PETV) and enVVeno Medical (NASDAQ:NVNO) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, media sentiment, institutional ownership, earnings, dividends and profitability.

24.5% of PetVivo shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 10.8% of PetVivo shares are held by company insiders. Comparatively, 15.0% of enVVeno Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

In the previous week, PetVivo had 2 more articles in the media than enVVeno Medical. MarketBeat recorded 4 mentions for PetVivo and 2 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 0.43 beat PetVivo's score of 0.00 indicating that enVVeno Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
PetVivo	Neutral
enVVeno Medical	Neutral

enVVeno Medical has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. enVVeno Medical's return on equity of -62.28% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
enVVeno Medical	N/A	-62.28%	-56.83%

PetVivo has higher revenue and earnings than enVVeno Medical. PetVivo is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	24.67	-$10.95M	-$0.38	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$19.33	N/A

PetVivo has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market.

Summary

enVVeno Medical beats PetVivo on 9 of the 14 factors compared between the two stocks.

How does enVVeno Medical compare to Cytosorbents?

Cytosorbents (NASDAQ:CTSO) and enVVeno Medical (NASDAQ:NVNO) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, media sentiment, risk, earnings and profitability.

In the previous week, Cytosorbents had 8 more articles in the media than enVVeno Medical. MarketBeat recorded 10 mentions for Cytosorbents and 2 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 0.43 beat Cytosorbents' score of -0.50 indicating that enVVeno Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Cytosorbents	Negative
enVVeno Medical	Neutral

enVVeno Medical has a net margin of 0.00% compared to Cytosorbents' net margin of -48.94%. enVVeno Medical's return on equity of -62.28% beat Cytosorbents' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cytosorbents	-48.94%	-431.65%	-41.94%
enVVeno Medical	N/A	-62.28%	-56.83%

Cytosorbents has higher revenue and earnings than enVVeno Medical. Cytosorbents is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cytosorbents	$37.06M	0.68	-$8.20M	-$0.29	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$19.33	N/A

Cytosorbents has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market.

Cytosorbents presently has a consensus target price of $5.38, suggesting a potential upside of 1,244.09%. Given Cytosorbents' higher probable upside, analysts clearly believe Cytosorbents is more favorable than enVVeno Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cytosorbents	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

32.9% of Cytosorbents shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 7.8% of Cytosorbents shares are owned by insiders. Comparatively, 15.0% of enVVeno Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Cytosorbents and enVVeno Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does enVVeno Medical compare to Lifeward?

Lifeward (NASDAQ:LFWD) and enVVeno Medical (NASDAQ:NVNO) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk.

In the previous week, Lifeward had 4 more articles in the media than enVVeno Medical. MarketBeat recorded 6 mentions for Lifeward and 2 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 0.43 beat Lifeward's score of 0.26 indicating that enVVeno Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Lifeward	Neutral
enVVeno Medical	Neutral

26.8% of Lifeward shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 1.5% of Lifeward shares are held by company insiders. Comparatively, 15.0% of enVVeno Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

enVVeno Medical has lower revenue, but higher earnings than Lifeward. enVVeno Medical is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$22.03M	0.96	-$19.91M	-$19.66	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$19.33	N/A

enVVeno Medical has a net margin of 0.00% compared to Lifeward's net margin of -123.66%. enVVeno Medical's return on equity of -62.28% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-123.66%	-243.14%	-97.39%
enVVeno Medical	N/A	-62.28%	-56.83%

Lifeward has a beta of 0.38, meaning that its share price is 62% less volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.1, meaning that its share price is 10% more volatile than the broader market.

Lifeward currently has a consensus target price of $10.00, indicating a potential upside of 34.23%. Given Lifeward's higher probable upside, equities research analysts plainly believe Lifeward is more favorable than enVVeno Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

Summary

enVVeno Medical beats Lifeward on 11 of the 16 factors compared between the two stocks.

How does enVVeno Medical compare to Jin Medical International?

enVVeno Medical (NASDAQ:NVNO) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk.

Jin Medical International has higher revenue and earnings than enVVeno Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enVVeno Medical	N/A	N/A	-$19.47M	-$19.33	N/A
Jin Medical International	$20.69M	12.81	$1.19M	N/A	N/A

In the previous week, Jin Medical International had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 3 mentions for Jin Medical International and 2 mentions for enVVeno Medical. Jin Medical International's average media sentiment score of 1.12 beat enVVeno Medical's score of 0.43 indicating that Jin Medical International is being referred to more favorably in the news media.

Company	Overall Sentiment
enVVeno Medical	Neutral
Jin Medical International	Positive

Jin Medical International's return on equity of 0.00% beat enVVeno Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
enVVeno Medical	N/A	-62.28%	-56.83%
Jin Medical International	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

34.7% of enVVeno Medical shares are held by institutional investors. 15.0% of enVVeno Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

enVVeno Medical has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.34, meaning that its stock price is 634% more volatile than the broader market.

Summary

Jin Medical International beats enVVeno Medical on 7 of the 11 factors compared between the two stocks.

How does enVVeno Medical compare to Adagio Medical?

Adagio Medical (NASDAQ:ADGM) and enVVeno Medical (NASDAQ:NVNO) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.

enVVeno Medical's return on equity of -62.28% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-661.85%	-73.35%
enVVeno Medical	N/A	-62.28%	-56.83%

Adagio Medical has a beta of -0.15, suggesting that its share price is 115% less volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.1, suggesting that its share price is 10% more volatile than the broader market.

Adagio Medical currently has a consensus price target of $3.50, indicating a potential upside of 405.63%. Given Adagio Medical's higher probable upside, research analysts clearly believe Adagio Medical is more favorable than enVVeno Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

enVVeno Medical is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	N/A	N/A	-$25.08M	-$1.48	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$19.33	N/A

In the previous week, Adagio Medical had 2 more articles in the media than enVVeno Medical. MarketBeat recorded 4 mentions for Adagio Medical and 2 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 0.43 beat Adagio Medical's score of -0.28 indicating that enVVeno Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Adagio Medical	Neutral
enVVeno Medical	Neutral

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 7.8% of Adagio Medical shares are owned by insiders. Comparatively, 15.0% of enVVeno Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

enVVeno Medical beats Adagio Medical on 8 of the 14 factors compared between the two stocks.

Get enVVeno Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NVNO vs. The Competition

Export

Metric	enVVeno Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$7.41M	$5.88B	$7.04B	$13.07B
Dividend Yield	N/A	1.76%	2.57%	10.45%
P/E Ratio	-0.56	26.59	270.72	25.33
Price / Sales	N/A	63.44	574.42	74.73
Price / Cash	N/A	33.92	70.48	50.90
Price / Book	0.36	6.17	12.92	6.25
Net Income	-$19.47M	$149.27M	$3.45B	$347.82M
7 Day Performance	2.29%	2.04%	1.16%	1.08%
1 Month Performance	0.86%	4.17%	1.38%	0.82%
1 Year Performance	-93.68%	9.34%	62.53%	20.99%

enVVeno Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NVNO enVVeno Medical	1.533 of 5 stars	$10.85 +0.0%	N/A	-93.1%	$7.41M	N/A	N/A	30	Short Interest Increase
PETV PetVivo	N/A	$0.69 -4.5%	N/A	-13.3%	$26.19M	$1.05M	N/A	20	News Coverage Gap Down
CTSO Cytosorbents	1.7629 of 5 stars	$0.37 +2.8%	$5.38 +1,352.7%	-64.9%	$22.62M	$37.06M	N/A	220	News Coverage Analyst Revision
LFWD Lifeward	2.2089 of 5 stars	$7.75 +2.4%	$10.00 +29.0%	+1.4%	$21.40M	$22.03M	N/A	60	News Coverage Earnings Report
ZJYL Jin Medical International	1.3201 of 5 stars	$3.49 +17.1%	N/A	-73.3%	$20.35M	$20.69M	N/A	245	Positive News Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NVNO) was last updated on 8/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

enVVeno Medical (NVNO) Competitors

NVNO vs. PETV, CTSO, LFWD, ZJYL, and ADGM

How does enVVeno Medical compare to PetVivo?

Summary

How does enVVeno Medical compare to Cytosorbents?

Summary

How does enVVeno Medical compare to Lifeward?

Summary

How does enVVeno Medical compare to Jin Medical International?

Summary

How does enVVeno Medical compare to Adagio Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVNO vs. The Competition

enVVeno Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

enVVeno Medical (NVNO) Competitors

NVNO vs. PETV, CTSO, LFWD, ZJYL, and ADGM

How does enVVeno Medical compare to PetVivo?

Do insiders and institutionals believe in PETV or NVNO?

Do analysts recommend PETV or NVNO?

Does the media prefer PETV or NVNO?

Is PETV or NVNO more profitable?

Which has higher valuation & earnings, PETV or NVNO?

Which has more risk and volatility, PETV or NVNO?

Summary

How does enVVeno Medical compare to Cytosorbents?

Does the media prefer CTSO or NVNO?

Is CTSO or NVNO more profitable?

Which has preferable valuation & earnings, CTSO or NVNO?

Which has more volatility and risk, CTSO or NVNO?

Do analysts prefer CTSO or NVNO?

Do insiders & institutionals have more ownership in CTSO or NVNO?

Summary

How does enVVeno Medical compare to Lifeward?

Does the media favor LFWD or NVNO?

Do insiders and institutionals believe in LFWD or NVNO?

Which has higher valuation and earnings, LFWD or NVNO?

Is LFWD or NVNO more profitable?

Which has more volatility and risk, LFWD or NVNO?

Do analysts rate LFWD or NVNO?

Summary

How does enVVeno Medical compare to Jin Medical International?

Which has stronger valuation and earnings, NVNO or ZJYL?

Does the media favor NVNO or ZJYL?

Is NVNO or ZJYL more profitable?

Do analysts recommend NVNO or ZJYL?

Do institutionals and insiders hold more shares of NVNO or ZJYL?

Which has more volatility & risk, NVNO or ZJYL?

Summary

How does enVVeno Medical compare to Adagio Medical?

Is ADGM or NVNO more profitable?

Which has more risk & volatility, ADGM or NVNO?

Do analysts recommend ADGM or NVNO?

Which has stronger earnings and valuation, ADGM or NVNO?

Does the media prefer ADGM or NVNO?

Do institutionals & insiders believe in ADGM or NVNO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVNO vs. The Competition

enVVeno Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools